T vs TERN · P/E 7.4, rev $125.65B vs $6.12B cap
AT&T Inc. (T) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
AT&T Inc. (T) is a telecom services company listed on NYSE. It is led by John Stankey.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported T revenue for 2025-12-31 was $125.65B. Net income was $21.95B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. T currently screens at market cap $155.92B and trailing P/E 7.4.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
T currently screens at market cap $155.92B and trailing P/E 7.4. TERN currently screens at market cap $6.12B.
Not investment advice. Open the T and TERN stock pages for the full models.
Not investment advice.